Show simple item record

dc.contributor.authorHenden, Edmunden_US
dc.contributor.authorBærøe, Kristineen_US
dc.date.accessioned2015-05-19T12:49:12Z
dc.date.available2015-05-19T12:49:12Z
dc.date.issued2015-02-02eng
dc.identifier.issn0955-6036
dc.identifier.urihttps://hdl.handle.net/1956/9899
dc.description.abstractProviding heroin to people with heroin addiction taking part in medical trials assessing the effectiveness of the drug as a treatment alternative breaches ethical research standards, some ethicists maintain. Heroin addicts, they say, are unable to consent voluntarily to taking part in these trials. Other ethicists disagree. In our view, both sides of the debate have an inadequate understanding of ‘voluntariness’. In this article we therefore offer a fuller definition of the concept, one which allows for a more flexible, case-to-case approach in which some heroin addicts are considered capable of consenting voluntarily, others not. An advantage of this approach, it is argued, is that it provides a safety net to minimise the risk of inflicting harm on trial participants.en_US
dc.language.isoengeng
dc.publisherThe Royal College of Psychiatristseng
dc.rightsAttribution CC BYeng
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/eng
dc.titleProviding free heroin to addicts participating in research - ethical concerns and the question of voluntarinessen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2015-04-08T09:52:06Zen_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2014 The Authors
dc.identifier.doihttps://doi.org/10.1192/pb.bp.113.046565
dc.identifier.cristin1145901
dc.source.journalPsychiatric bulletin of the Royal College of Psychiatrists
dc.source.4039
dc.source.pagenumber28-31
dc.relation.projectNorges forskningsråd: 213064


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY